Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 |
|---|---|---|---|---|
Total Revenue | 2,775 | -- | (31) | -- |
Cost of Revenue | -- | -- | -- | -- |
Gross Profit | -- | -- | (31) | -- |
Operating Expenses | ||||
Research Development | -- | -- | -- | -- |
Selling General and Administrative | 632 | 591 | 801 | -- |
Non Recurring | -- | -- | -- | -- |
Others | 1,141 | 1,178 | 1,205 | -- |
Total Operating Expenses | 1,773 | 1,769 | 2,006 | -- |
Operating Income or Loss | (1,773) | (1,769) | (2,037) | -- |
Income from Continuing Operations | ||||
Total Other Income/Expenses Net | (697) | (712) | (680) | -- |
Earnings Before Interest And Taxes | 791 | 530 | 473 | -- |
Interest Expense | -- | -- | -- | -- |
Income Before Tax | 197 | 29 | 75 | -- |
Income Tax Expense | 27 | (10) | 2 | -- |
Minority Interest | -- | -- | -- | -- |
Net Income From Continuing Ops | 170 | 39 | 73 | -- |
Non-recurring Events | ||||
Discontinued Operations | -- | -- | -- | -- |
Extraordinary Items | -- | -- | -- | -- |
Effect Of Accounting Changes | -- | -- | -- | -- |
Other Items | 0 | 0 | 0 | -- |
Net Income | 170 | 39 | 73 | -- |
Preferred Stock And Other Adjustments | -- | -- | -- | -- |
Net Income Applicable To Common Shares | 170 | 39 | 73 | -- |